Related Experiment Video
Updated: May 15, 2026

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
ECM17-dependent methionine/cysteine biosynthesis contributes to biofilm formation in Candida albicans
De-Dong Li1, Yan Wang, Bao-Di Dai
1School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
Abstract:
Candida albicans has become the fourth leading pathogen of nosocomial bloodstream infections largely due to biofilm formation on implanted medical devices. Previous microarray data indicated that almost all genes in methionine (Met)/cysteine (Cys) biosynthesis pathway were up-regulated during biofilm formation, especially during the adherence period. In this work, we studied the role of Met/Cys biosynthesis pathway by disrupting ECM17, a gene encoding sulfite reductase in C. albicans. It was found that the ecm17Δ/Δ mutant failed to catalyze the biochemical reaction from sulfite to H(2)S and hardly grew in media lacking Met and Cys. NaSH, the donor of H(2)S, dose-dependently improved the growth of ecm17Δ/Δ in media lacking a sulfur source. Sufficient Met/Cys supply inhibited the expression of ECM17 in a dose-dependent manner. These results validated the important role of ECM17 in Met/Cys biosynthesis. Interestingly, the ecm17Δ/Δ mutant showed diminished ability to form biofilm, attenuated adhesion on abiotic substrate and decreased filamentation on solid SLD medium, especially under conditions lacking Met/Cys. Further results indicated that ECM17 affected the expressions of ALS3, CSH1, HWP1 and ECE1, and that the cAMP-protein kinase A (PKA) pathway was associated with ECM17 and Met/Cys biosynthesis pathway. These results provide new insights into the role of Met/Cys biosynthesis pathway in regulating cAMP-PKA pathway and benefiting biofilm formation.
Insights
Disrupting the ECM17 gene in Candida albicans impairs methionine/cysteine biosynthesis and significantly reduces biofilm formation and adhesion. This highlights the crucial role of this pathway in fungal virulence.
Area of Science:
- Medical Mycology
- Molecular Biology
- Biochemistry
Background:
- Candida albicans is a leading cause of nosocomial infections, often forming biofilms on medical devices.
- Methionine/cysteine biosynthesis genes are upregulated during C. albicans biofilm formation.
Purpose of the Study:
- To investigate the role of the methionine/cysteine biosynthesis pathway, specifically the ECM17 gene, in C. albicans biofilm formation and virulence.
- To elucidate the relationship between ECM17, methionine/cysteine metabolism, and the cAMP-protein kinase A (PKA) pathway.
Main Methods:
- Gene disruption of ECM17 in C. albicans to create an ecm17Δ/Δ mutant.
- Assessing mutant growth in media with varying methionine/cysteine and H2S (NaSH) concentrations.
- Evaluating biofilm formation, adhesion, and filamentation of the mutant.
- Analyzing the expression of virulence genes (ALS3, CSH1, HWP1, ECE1) and the cAMP-PKA pathway.
Main Results:
- The ecm17Δ/Δ mutant failed to produce H2S and exhibited poor growth without methionine/cysteine, which was rescued by NaSH.
- ECM17 expression was downregulated by methionine/cysteine supply.
- The ecm17Δ/Δ mutant showed reduced biofilm formation, adhesion, and filamentation, particularly under nutrient-limited conditions.
- ECM17 disruption affected the expression of ALS3, CSH1, HWP1, and ECE1, and was linked to the cAMP-PKA pathway.
Conclusions:
- ECM17 is essential for methionine/cysteine biosynthesis in C. albicans.
- The methionine/cysteine biosynthesis pathway, regulated by ECM17, plays a significant role in C. albicans biofilm formation, adhesion, and filamentation.
- ECM17 and methionine/cysteine metabolism are connected to the cAMP-PKA pathway, influencing fungal virulence.
Related Concept Videos
Biofilms
Sulfur Assimilation
Amino Acid Catabolism
Role of Microtubules in Cell Wall Deposition

